Eli Lilly brings Oura smart ring to LillyDirect platform
The pharma giant is pushing GLP-1 care beyond the prescription pad, now offering patients free ring sizing kits and biometric tracking tools
Owkin partners with Sanofi to build custom AI agents for drug discovery
Five-year collaboration will create specialized AI assistants using Owkin's K Pro platform to automate pharmaceutical research tasks
Samsung Galaxy Watch8 to help monitor muscle loss in GLP-1 patients
Clinical study with Massachusetts General Hospital will track body composition changes during popular weight-loss treatments
GoodRx launches $15 monthly membership to tackle rising healthcare costs
New subscription program combines free generic drugs, $19 telehealth visits, and discounted dental and vision care
FDA launches real-time clinical trials to speed up drug development
Two proof-of-concept trials now report data directly to regulators as studies progress, with broader pilot program coming this summer
OpenAI launches GPT-Rosalind AI model for life sciences research
New model named after DNA pioneer aims to speed up drug discovery and biochemistry research
Amazon launches nationwide weight-loss program with GLP-1 drugs
The retail giant integrates popular diabetes and weight-loss medications into its healthcare services with transparent pricing and delivery
AI medical scribes get smart glasses upgrade for better patient notes
Vision-enabled AI scribes achieve 98% accuracy compared to 81% for audio-only systems
Anthropic buys AI biotech startup Coefficient Bio for $400 million
The deal brings drug discovery expertise to the Claude maker as it expands into healthcare
Insilico Medicine partners with Eli Lilly in $2.75 billion AI drug discovery deal
The collaboration combines AI-driven drug discovery with Lilly's clinical development expertise across multiple diseases